Latest filing published 20 Apr 2026 for SunOpta Inc., €8,989. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Albert D. Bolles (chief executive) discloses dealings in 2 companies, chiefly SunOpta Inc. and Lifecore Biomedical, Inc. \DE\. The record holds 26 filings, for trades running from 22 June 2021 to 17 April 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 20 April 2026, the filings show a share grant worth €8,989 in SunOpta Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations